# A Study of AK002 in Patients With Atopic Keratoconjunctivitis, Vernal Keratoconjunctivitis, and Perennial Allergic Conjunctivitis

> **NCT03379311** · PHASE1 · COMPLETED · sponsor: **Allakos Inc.** · enrollment: 30 (actual)

## Conditions studied

- Atopic Keratoconjunctivitis
- Vernal Keratoconjunctivitis
- Perennial Allergic Conjunctivitis

## Interventions

- **DRUG:** AK002

## Key facts

- **NCT ID:** NCT03379311
- **Lead sponsor:** Allakos Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-26
- **Primary completion:** 2019-08-08
- **Final completion:** 2019-08-08
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03379311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03379311, "A Study of AK002 in Patients With Atopic Keratoconjunctivitis, Vernal Keratoconjunctivitis, and Perennial Allergic Conjunctivitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03379311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*